Dexamethasone, rituximab and cyclophosphamide (DRC) in relapsed/refractory (R/R) and treatment naïve (TN) Waldenström macroglobulinemia (WM).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jonas Paludo, Jithma P. Abeykoon, Morie A. Gertz, Shaji Kumar, Rebecca L King, Robert A. Kyle, Francis Buadi, Suzanne R. Hayman, Thomas Matthew Habermann, David Dingli, Thomas E. Witzig, Angela Dispenzieri, Martha Lacy, Carrie A. Thompson, Ronald S. Go, Wilson I. Gonsalves, John Anthony Lust, S. Vincent Rajkumar, Stephen Maxted Ansell, Prashant Kapoor
Institution: Mayo Clinic
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890760598